A novel disease modifying therapy for progression of pulmonary arterial hypertension
Ended Project Grant Awarded Last action
- Award ID
- R43HL149496
- Recipient
-
Vasculonics Inc. UEI KASJGN8XW8P8
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $211,943
Award facts
- Assistance listing
- 93.837 Cardiovascular Diseases Research
- Completion date
- Originally
- Place of performance
- Indiana, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | -$5,958 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $217,901 |
Quick answers
Who received award R43HL149496?
R43HL149496 was awarded to Vasculonics Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on August 23, 2019.
How much is award R43HL149496 worth?
$211,943 has been obligated on R43HL149496.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award